Expression of Beclin-1 in non-small cell lung cancer and its clinical significance

肖瑜,龙驰,张明慧,罗焱,胡义德
DOI: https://doi.org/10.16016/j.1000-5404.2013.12.038
2013-01-01
Abstract:Objective To investigate the expression level of an important autophagy-related factor Beclin-1 in non-small cell lung cancer(NSCLC) and its clinical significance.Methods The specimens of carcinoma tissues and their paired para-carcinoma tissues collected from 150 NSCLC patients were made into tissue microarray.Immunohistochemistry(IHC) was applied to detect the expression level of Beclin-1 in these specimens.The correlation between the expression level of Beclin-1 and the survive rate of patients with NSCLC was analyzed.Results The positive expression rate of Beclin-1 in the carcinoma tissues(26.00%) was significantly lower than that in the para-carcinoma tissues(82.00%)(P<0.05),and the positive expression rate of Beclin-1 in squamous cell carcinoma tissues(34.66%) was significantly higher than that in the adenocarcinoma tissues(17.34%)(P<0.05).However,no evidence showed the expression rate of Beclin-1 was correlated with sex,age,degrees of differentiation,lymph node metastasis and distant metastasis(P>0.05).The survive rate of the NSCLC patients with negative expression of Beclin-1 was significantly lower than that of the NSCLC patients with positive expression of Beclin-1(P<0.05).Conclusion Beclin-1 may be used as a new target for NSCLC treatment and as a potential indicator for pathological diagnosis and prognostic prediction of NSCLC.
What problem does this paper attempt to address?